Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Five Stocks To Buy: BSE, Infosys, ICICI Bank And More | May 19, 2026
Top picks include financial market infrastructure major BSE, IT giants Infosys and Coforge, pharmaceutical major Sun Pharma, and private sector lender ICICI Bank.
Vinay Rajani of HDFC Sec suggests Oracle Financial Services, Sun Pharma shares to buy
Indian equity markets experienced a significant selloff on May 18, with Sensex and Nifty 50 dropping over 1%. The BSE Sensex fell over 1,000 points, erasing nearly ₹9 lakh crore in investor wealth amid weak global cues and a bearish trend across sectors.
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Performance This Week
Nifty above 23,500 level; pharma shares in demand
At 10:30 IST, the barometer index, the S&P BSE Sensex, advanced 228.50 points or 0.31% to 74,837.48. The Nifty 50 index rose 98.85 points or 0.42% to 23,511.40.
Sun Pharma Share Price Live Updates: Sun Pharma's trading activity
Schaeffler India opens computational research infrastructure at FSID, IISC
Schaeffler India has announced the opening of a computational research infrastructure at the Foundation for Science Innovation and Development (FSID), Bengaluru. Part of Schaeffler India's purposeful engagement with IISC, premium research academia, this supported facility strengthens research capabilities by enabling HPC (High- Performance Computing) large-scale simulations, data-intensive modelling and advanced analytics across materials, energy systems, and sustainable mobility. Additionally, these improvements will foster stronger industry collaborations, improved research quality and efficiency, and increased relevance of research in industry projects.
Sun Pharma Share Price Live Updates: Sun Pharma's Monthly Return Highlights
Sun Pharma Share Price Live Updates: Sun Pharma's beta reflects market stability
Sensex slumps 847 pts; Nifty trades below 23,950 mark; VIX rallies 8.40%
The Nifty slipped below the 23,950 mark. Pharma, IT and FNCG shares advanced while all the sectoral indices on the NSE traded in the red.
Organon deal impact: Sun Pharma surges 16% in 10 days, nears record high
Sun Pharma's acquisition of Organon as a transformational deal, doubling revenue to USD 12 billion with 30 per cent EBITDA margin, analysts.
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Insights
Trade Spotlight: How should you trade Goodluck India, CreditAccess, Sun Pharma, Gravita India, Ratnamani... - Moneycontrol.com
Trade Spotlight: How should you trade Goodluck India, CreditAccess, Sun Pharma, Gravita India, Ratnamani...Moneycontrol.com